NCT01700725

Brief Summary

The purpose of this study is to determine whether nasal irrigation with Xylitol or saline are effective in the treatment of chronic rhinosinusitis and fatigue symptoms associated with Gulf War Illness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Oct 2012

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2012

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2012

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 4, 2012

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2017

Completed
2.1 years until next milestone

Results Posted

Study results publicly available

May 21, 2019

Completed
Last Updated

May 21, 2019

Status Verified

May 1, 2019

Enrollment Period

3.7 years

First QC Date

August 14, 2012

Results QC Date

April 9, 2019

Last Update Submit

May 3, 2019

Conditions

Keywords

Gulf War Illnessxylitolnasal irrigationDesert StormPersian Gulf Conflictsneti potcytokinesnasal mucusinflammatory mediatorlactoferrinlysozyme

Outcome Measures

Primary Outcomes (1)

  • Change in Sino-Nasal Outcome Test (SNOT-20) Score From Baseline

    Sino-Nasal Outcome Test (SNOT-20) is a recommended tool for clinical trial research involving CRS. Sinus disease specific quality of life will be measured using the total score of this validated 20 item questionnaire. It is a reliable and valid outcome measure for patients with CRS (Cronbach's α 0.9, test-retest r = 0.9) that describes the health burden and is sensitive to clinical change. Patients who are more affected by CRS tend to have greater SNOT-20 scores (P \< 0.01). The SNOT-20 score is expected to improve in NI-treated subjects compared to controls. Findings of the PI's prior RCT of adults with CRS are consistent with the above evidence. The total range of possible scores is 0-100. The higher the score, the worse the symptoms.

    Change from baseline week 8, change from baseline week 26

Secondary Outcomes (2)

  • Change in Multidimensional Fatigue Inventory (MFI) Over Baseline

    Baseline to weeks 8 & 26

  • Change in Medical Outcomes Survey Short Form-36 (SF-36) Over Baseline

    Baseline and weeks 8 & 26

Study Arms (3)

Nasal Irrigation - Saline

EXPERIMENTAL

nasal irrigation using saline plus routine care for symptoms of CRS and fatigue

Other: Nasal Irrigation - Saline

Nasal Irrigation - Xylitol

EXPERIMENTAL

Nasal Irrigation with Xylitol plus routine care for symptoms of CRS and fatigue

Drug: Nasal Irrigation - Xylitol

Control Group

NO INTERVENTION

Control group subjects continue to use routine care only

Interventions

Liquid-based nasal irrigation (NI) is performed using a nasal irrigation cup ("neti pot"), a simple hand-held vessel that uses the force of gravity to gently irrigate the user's nasal cavity. Subjects will be requested to perform NI twice daily. The subjects will prepare the saline solution by themselves using the study-provided kit which will include packets of salt powder and the neti pot; subjects will dissolve the powder in lukewarm tap water to achieve a 2% buffered saline solution. The solution is then delivered to the nasal cavity using neti pot.

Also known as: 2% buffered saline
Nasal Irrigation - Saline

Liquid-based nasal irrigation (NI) is performed using a nasal irrigation cup ("neti pot"), a simple hand-held vessel that uses the force of gravity to gently irrigate the user's nasal cavity. Subjects will be requested to perform NI twice daily. The subjects will prepare the Xylitol solution by themselves using the study-provided kit which will include packets of Xylitol powder and the neti pot; subjects will dissolve the powder in lukewarm tap water to achieve a 5% Xylitol solution. The solution is then delivered to the nasal cavity using neti pot.

Also known as: 5% Xylitol solution
Nasal Irrigation - Xylitol

Eligibility Criteria

Age35 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • English fluency and basic reading and writing literacy.
  • Deployment to the Persian Gulf (e.g., Iraq, Kuwait, Saudi Arabia) for the purpose of Operation Desert Shield or Operation Desert Storm during the first Gulf War (1990-1991).
  • Meeting criteria for a diagnosis of GWI as based on the "Kansas" GWI case definition; only the Kansas case definition (from among the several currently used case definitions) can differentiate between Gulf War-deployed and non-deployed Gulf era veterans.
  • Meeting criteria for a diagnosis of chronic rhinosinusitis (CRS) using self-reported symptoms and based on clinical guidelines; eligible subjects will report: • sinonasal symptoms for at least 12 weeks; • a constellation of sinonasal symptoms including either two or more major factors, or 1 major and 2 minor factors (see Table 1 below), or chronic nasal purulence for 12 or more weeks; and • a moderate to severe HRQoL impact (≥ 3 points on a 0-10 Likert severity scale) as assessed by a single item question:11 "What has been the average level of your sinus symptoms daily over the past month on a 0-10 scale?" This item is consistent with eligibility criteria used in prior NI studies.
  • Chronic fatigue of moderate-to-severe severity defined as scoring at least 3 points on a single question (0-10 Likert scale): "What has been the average level of your daily fatigue over the past month on a 0-10 scale?"

You may not qualify if:

  • Self-reported pregnancy.
  • Current use of liquid NI or xylitol nasal spray; regular use is defined as 1 or more irrigations weekly for 3 consecutive weeks.
  • Self-reported neurological or musculoskeletal conditions that could facilitate aspiration, or patients who otherwise cannot physically perform the NI procedure.
  • Self-reported borderline personality disorder.
  • Inability or stated reluctance to reliably participate in study activities.
  • Severe or unstable mental health problems that would preclude safe or reliable study participation as based on an in-person evaluation by a psychiatry team; active delusional disorder, depressive disorder or alcohol/drug abuse or dependence will be a primary target of this interview using both a structured clinical interview (MINI ref) and psychiatry team evaluation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Wisconsin General Clinical Research Center

Madison, Wisconsin, 53792, United States

Location

Related Publications (1)

  • Hayer SD, Rabago DP, Amaza IP, Kille T, Coe CL, Zgierska A, Zakletskaia L, Mundt MP, Krahn D, Obasi CN, Molander RC. Effectiveness of nasal irrigation for chronic rhinosinusitis and fatigue in patients with Gulf War illness: protocol for a randomized controlled trial. Contemp Clin Trials. 2015 Mar;41:219-26. doi: 10.1016/j.cct.2015.01.008. Epub 2015 Jan 24.

MeSH Terms

Conditions

Persian Gulf SyndromeFatigue

Condition Hierarchy (Ancestors)

Occupational DiseasesWar-Related InjuriesWounds and InjuriesSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
David Rabago, MD
Organization
University of Wisconsin - Madison

Study Officials

  • Rachel Molander, MD

    US Department of Veterans Affairs, William S. Middleton Memorial Veterans Hospital

    PRINCIPAL INVESTIGATOR
  • David P Rabago, MD

    University of Wisconsin, Madison

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 14, 2012

First Posted

October 4, 2012

Study Start

October 1, 2012

Primary Completion

June 1, 2016

Study Completion

May 1, 2017

Last Updated

May 21, 2019

Results First Posted

May 21, 2019

Record last verified: 2019-05

Locations